16926224

Source:http://linkedlifedata.com/resource/pubmed/id/16926224

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0030705, umls-concept:C0034656, umls-concept:C0149256, umls-concept:C0282460, umls-concept:C1336219, umls-concept:C1522449, umls-concept:C1527392
pubmed:issue	9
pubmed:dateCreated	2006-10-9
pubmed:abstractText	To find the optimal dose of immunomodulator Z-100 in patients with stage IIIB squamous cell carcinoma of the cervix in combination with radiation therapy.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0313225
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Lipids, http://linkedlifedata.com/resource/pubmed/chemical/Mannans, http://linkedlifedata.com/resource/pubmed/chemical/specific substance maruyama
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	0368-2811
pubmed:author	pubmed-author:FujiiShingoS, pubmed-author:FujiwaraKeiichiK, pubmed-author:HashimotoShozoS, pubmed-author:HoriuchiJunichiJ, pubmed-author:KikuchiYuzoY, pubmed-author:MoritaKozoK, pubmed-author:NiibeHideoH, pubmed-author:NodaKiichiroK, pubmed-author:OgitaSachioS, pubmed-author:OhashiYasuoY, pubmed-author:OkadaHirojiH, pubmed-author:OzakiMasamiM, pubmed-author:TakegawaYoshihiroY
pubmed:issnType	Print
pubmed:volume	36
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	570-7
pubmed:meshHeading	pubmed-meshheading:16926224-Adolescent, pubmed-meshheading:16926224-Adult, pubmed-meshheading:16926224-Aged, pubmed-meshheading:16926224-Aged, 80 and over, pubmed-meshheading:16926224-Antineoplastic Agents, pubmed-meshheading:16926224-Brachytherapy, pubmed-meshheading:16926224-Carcinoma, Squamous Cell, pubmed-meshheading:16926224-Combined Modality Therapy, pubmed-meshheading:16926224-Drug Administration Schedule, pubmed-meshheading:16926224-Female, pubmed-meshheading:16926224-Humans, pubmed-meshheading:16926224-Lipids, pubmed-meshheading:16926224-Mannans, pubmed-meshheading:16926224-Middle Aged, pubmed-meshheading:16926224-Neoplasm Staging, pubmed-meshheading:16926224-Radiotherapy Dosage, pubmed-meshheading:16926224-Registries, pubmed-meshheading:16926224-Survival Rate, pubmed-meshheading:16926224-Uterine Cervical Neoplasms
pubmed:year	2006
pubmed:articleTitle	Randomized phase II study of immunomodulator Z-100 in patients with stage IIIB cervical cancer with radiation therapy.
pubmed:affiliation	Kinki University, Japan.
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase II